Ab interno canaloplasty (ABiC) truly is the next generation of MIGS (minimally invasive glaucoma surgery). With a mild touch and manifest efficacy, it is a swift procedure that preserves the conjunctiva, with great outcomes and a fast recovery and can be performed both during and independently of cataract surgery. It is a compelling option for IOP lowering in many patients, and can also help to effectively reduce the medication burden in patients suffering from controlled or uncontrolled glaucoma.

In the monthly ABiC Blog, MIGS expert Dr. Mark Gallardo will highlight ongoing developments in the world of MIGS – and the important role to be played by ABiC and the various MIGS options in the glaucoma treatment algorithm. Dr. Gallardo is a glaucoma specialist and is one of the pioneers of the ABiC procedure. He is in private practice at El Paso Eye Surgeons, Texas, and is affiliated with Hospitals of Providence Sierra Campus, Las Palmas Medical Center and University Medical Center of El Paso, Texas, USA.

30 June 2018Diving into the Suprachoroidal Space

Author: Dr. Mark J. Gallardo, MD

It’s July, it’s hot, and it’s time for a beach vacation on the California coast (no financial interest in California) and some surfing lessons.  To novices like myself, the waters in La Jolla can be treacherous, with rolling waves and, sometimes, an undertow.  To others, especially those with experience in the water, the surf is viewed as mild and easily navigated. For those of you who don’t know, an undertow (or rip current) is when a narrow current that strongly…

28 May 2018Why the Eye’s Outflow System is Like a Highway

Author: Dr. Mark J. Gallardo, MD

As I continue my studies of natural aqueous outflow, I have become happily aware of just how intricate and complex the eye can be.  But as a resident, and then fellow, and sorrowfully admitting, as a doc who is now well beyond the years of being considered a YO (young ophthalmologist) my understanding of trabecular outflow was infantile at best.   I believe my meager understanding of the conventional outflow system was multifactorial in nature.  One principle reason is our limited…

10 April 2018With All the Options We Have to Enhance Outflow, It’s a Great Time to be a Plumber (Part II)

Author: Dr. Mark J. Gallardo, MD

September 28, 1978: a day of infamy for glaucoma. A new drug that was to be milder on the eye and used earlier in the treatment paradigm to prevent blindness – a breakthrough in care – was announced during the CBS Evening News with Walter Cronkite.  Cronkite’s opening statement read, “Glaucoma, a painful disease of the eye that can lead to blindness, is not curable.  Drugs have been around for years, which can control the disease but often with such…

13 February 2018With All the Options We Have to Enhance Outflow, It’s a Great Time To Be a Plumber (Part 1)

Author: Dr. Mark J. Gallardo, MD

I can still remember the afternoon when I, a senior resident fascinated by technology, approached my long-time mentor and informed him that I had decided to apply for a fellowship in glaucoma.  I recall how he looked up from his seated position with his steel gray-blue eyes and intimidating stare.  I remember his exact words that he delivered with a shocked, dismayed, and disappointed voice: “Why on earth would you want to be a plumber?”.  You see, this faculty member,…

1 November 2017The Road less Traveled By: Dr. Mark Gallardo, MD

Author: Dr. Mark Gallardo, MD

Back in 2006, as an excited, energetic, and freshly graduated glaucoma surgeon, I attended the American Glaucoma Society Meeting in Dana Point, California.  There, for the first time, I was introduced to an amazing new thought process; there was world outside of tubes and trabs.  At my reps encouraging, I signed-up for and attended a symposium on canaloplasty and was blown away.  The procedure seemed so elegant, the technology so advanced.  We were using the world’s smallest catheter to circumnavigate…

1 August 2017MIGS: a time for less is now

Author: Dr. Mark Gallardo, MD

As a glaucoma specialist and member of the American Glaucoma Society I am privy to very intellectual discussions regarding challenging cases and various treatment options that are currently on the market. It seems that throughout the history of medicine, scientists, clinicians and surgeons have striven to develop treatment options that are more effective than their predecessors, offering enhanced efficacy and safety profiles.  I was reminded of this fact while reading an absolutely wonderful book, The Emperor of all Maladies, which…